About this ETF
The fund's advisor utilizes a systematic, data-driven quantitative framework to analyze U.S. common stocks, building an equity portfolio specifically designed to capture exposure to various investment factors. The process begins with an initial filter that eliminates the most volatile securities from the investment universe. Subsequently, stocks are selected based on an equally weighted composite score derived from three targeted factors: momentum, which identifies companies demonstrating strong recent price performance; quality, focusing on businesses with robust fundamental health; and value, selecting stocks trading at attractive prices relative to their underlying financial metrics. This approach yields a highly diversified portfolio consisting of hundreds of individual holdings, encompassing a broad range of market capitalizations—including large, mid, and small-cap companies—as well as various economic sectors and distinct industry groups, thereby minimizing stock-specific risks. The portfolio undergoes periodic rebalancing to ensure sustained alignment with its intended factor exposures. The primary investment objective is to achieve long-term capital growth. Generally, a minimum of 80% of the fund's assets will be allocated to equity securities issued by U.S. corporations. Specifically, the Value factor is determined using metrics such as book value-to-price, forward earnings-to-price, and operating cash flows-to-price (for non-financial firms). Momentum is assessed via total returns over the T-12 to T-1 month period and the T-7 to T-1 month period, in addition to the intercept from a one-year regression of stock returns against their regional benchmark. For financial companies, the Quality factor is gauged by return on equity and share issuance, while for non-financial companies, it involves return on equity, gross profitability, changes in net operating assets, and leverage. The initial volatility screen systematically removes the 20% most volatile names within each market capitalization tier and applies this equally across all sectors.
Description from the fund data provider · profile as of Aug 27, 2026.
Price Chart
Daily closing prices (price return, not total return). Comparison lines are normalized to percent change from the range start. Source: Financial Modeling Prep.
Performance
| 1M | 3M | 6M | YTD | 1Y | 3Y* | 5Y* | 10Y* | Incep.* | |
|---|---|---|---|---|---|---|---|---|---|
| Price return | +3.48% | +8.63% | +15.20% | +23.93% | +32.25% | +21.36% | +12.89% | — | +10.96% |
| Total return | +3.48% | +9.06% | +16.13% | +24.93% | +34.32% | +23.41% | +15.00% | — | +12.88% |
* Annualized. Total return uses the dividend-adjusted price series (distributions reinvested); price return uses unadjusted closes. Performance through Aug 25, 2026. Past performance does not guarantee future results.
Fees
| Net expense ratio | 0.18% | Annual cost of a $10,000 investment | $18.00 |
Illustrative calculation only: expense ratio × $10,000. It excludes trading costs, bid/ask spreads, taxes and changes in investment value. Gross vs. net expense details and any fee waivers are in the prospectus.
Holdings
Holdings as of Aug 26, 2026 — portfolio reporting date from the data provider; holdings are not live positions. 609 rows in database.
| # | Holding | Ticker | Weight | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | Micron Technology Inc | MU | 1.31% | 7.96K | $9.2M |
| 2 | Bristol-Myers Squibb Co | BMY | 0.90% | 110.46K | $6.4M |
| 3 | Newmont Corp | NEM | 0.90% | 67.51K | $6.3M |
| 4 | Travelers Cos Inc/The | TRV | 0.89% | 18.89K | $6.2M |
| 5 | Altria Group Inc | MO | 0.87% | 85.06K | $6.1M |
| 6 | Bank of New York Mellon Corp/The | BNY | 0.81% | 39.68K | $5.7M |
| 7 | ConocoPhillips | COP | 0.81% | 54.80K | $5.7M |
| 8 | Merck & Co Inc | MRK | 0.80% | 43.67K | $5.6M |
| 9 | EOG Resources Inc | EOG | 0.79% | 42.79K | $5.6M |
| 10 | AbbVie Inc | ABBV | 0.78% | 21.78K | $5.5M |
| 11 | Amgen Inc | AMGN | 0.75% | 14.62K | $5.3M |
| 12 | CVS Health Corp | CVS | 0.75% | 50.75K | $5.3M |
| 13 | Cisco Systems Inc | CSCO | 0.74% | 44.15K | $5.2M |
| 14 | Regeneron Pharmaceuticals Inc | REGN | 0.73% | 8.28K | $5.2M |
| 15 | QUALCOMM Inc | QCOM | 0.73% | 27.84K | $5.1M |
| 16 | Western Digital Corp | WDC | 0.73% | 8.01K | $5.1M |
| 17 | Allstate Corp/The | ALL | 0.71% | 20.91K | $5.0M |
| 18 | PepsiCo Inc | PEP | 0.68% | 35.14K | $4.8M |
| 19 | Alphabet Inc | GOOGL | 0.67% | 13.29K | $4.8M |
| 20 | HCA Healthcare Inc | HCA | 0.67% | 12.07K | $4.7M |
| 21 | ExxonMobil Holdings Corp | 7DZ.DE | 0.67% | 34.35K | $4.7M |
| 22 | Lam Research Corp | LRCX | 0.67% | 10.82K | $4.7M |
| 23 | Dell Technologies Inc | DELL | 0.66% | 10.78K | $4.7M |
| 24 | FedEx Corp | FDX | 0.63% | 14.19K | $4.4M |
| 25 | Gilead Sciences Inc | GILD | 0.63% | 35.06K | $4.4M |
Click a ticker to see every ETF that owns it.
Sector Exposure
Geographic Exposure
Country weights as reported by the data provider. Developed/emerging/frontier labels follow the classification on the Methodology page. Currency hedged: No hedging indicated in the fund name.
Distributions
| Yield (TTM) | 1.31% | Paid (last 12 months) | $2.4443 |
| Frequency | Quarterly | SEC yield | Not provided by our data source — see the issuer page |
| Last ex-date | Jun 24, 2026 | Last payment | $0.6819 (Jun 26, 2026) |
| Growth 1Y | +5.27% | Growth 3Y / 5Y (ann.) | +1.58% / +14.03% |
| Ex-date | Record | Pay date | Amount |
|---|---|---|---|
| Jun 24, 2026 | Jun 24, 2026 | Jun 26, 2026 | $0.6819 |
| Mar 24, 2026 | Mar 24, 2026 | Mar 26, 2026 | $0.6495 |
| Dec 23, 2025 | Dec 23, 2025 | Dec 26, 2025 | $0.6413 |
| Sep 24, 2025 | Sep 24, 2025 | Sep 26, 2025 | $0.4716 |
| Jun 20, 2025 | Jun 20, 2025 | Jun 24, 2025 | $0.6068 |
| Mar 25, 2025 | Mar 25, 2025 | Mar 27, 2025 | $0.6030 |
| Dec 23, 2024 | Dec 23, 2024 | Dec 26, 2024 | $0.5955 |
| Sep 26, 2024 | Sep 26, 2024 | Sep 30, 2024 | $0.5166 |
| Jun 27, 2024 | Jun 27, 2024 | Jul 01, 2024 | $0.5609 |
| Mar 21, 2024 | Mar 22, 2024 | Mar 26, 2024 | $0.4223 |
| Dec 19, 2023 | Dec 20, 2023 | Dec 22, 2023 | $0.5490 |
| Sep 21, 2023 | Sep 22, 2023 | Sep 26, 2023 | $0.4110 |
Trailing distribution yield = last 12 months of cash ÷ current price. It is NOT the SEC 30-day yield and distributions are not guaranteed to continue. The difference explained →
Risk Statistics
| Volatility 1Y / 3Y | 12.53% / 16.20% | Sharpe 1Y / 3Y | 2.54 / 1.33 |
| Max drawdown 1Y / 3Y | -7.08% / -20.57% | Sortino 1Y | 4.07 |
| Beta vs S&P 500 (3Y) | 0.88 | Correlation vs S&P 500 (1Y) | 0.734 |
| Downside deviation 1Y | 7.81% | Risk-free rate used | 3.72% (3M T-bill, FRED) |
Computed by ETF Explorer from daily dividend-adjusted closes; volatility and drawdown are annualized/period figures; S&P 500 exposure proxied by SPY. As of Aug 26, 2026. Formulas →
Liquidity
| Volume today | 29.87K | Average volume | 38.90K |
| AUM | $904.6M | Premium/Discount | +0.04% |
| Bid/Ask spread | Not provided by our data source. Check your broker's quote screen; spreads are widest at the open and close. | ||
Premium/discount compares the delayed market price with the last reported NAV — an indicative figure, not the official closing premium/discount. How ETF liquidity works →
Fund Flows (estimated)
| Period | Est. net flow | % of starting AUM | AUM start → end |
|---|---|---|---|
| 1 Day | $0.00 | 0.00% | $904.6M → $904.6M |
| 1 Week | -$1.9M | -0.21% | $904.6M → $904.6M |
ETF Explorer estimate: change in reported AUM minus the market-move effect, from our own daily snapshots. Not official issuer creation/redemption data.
Official Fund Resources
External links open the issuer's site or SEC EDGAR in a new tab. The prospectus and official documents are always the authoritative source — review them before investing.
Latest News for VFMF
No articles mention this fund directly in the last 7 days — showing general ETF coverage.
Guided help: AUM is fund size. The expense ratio is the yearly cost baked into returns. NAV is the value of what the fund owns per share; the market price can sit slightly above (premium) or below (discount) it. Total return assumes distributions were reinvested. Every dataset shows its own as-of date because holdings, assets and quotes update on different schedules.
VFMF